Biocartis, an innovative molecular diagnostics company, announces that it has received a € 1.4M grant from the Flemish Agency for Innovation by Science and Technology (IWT). Biocartis will use this grant to support the research and development of liquid biopsy versions of its solid tumour biopsy BRAF and KRAS diagnostic tests for melanoma and colorectal cancer, as well as research towards improved liquid biopsy methodologies.
Source: Biocartis